Catalyst Wire Dossier Catalyst Wire Dossier

Resveratol

Resveratrol
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Resveratol, covering 2026-01-12 to 2026-01-12. Get the full timeline:

Most recent: Clinical Trial Update: Resveratol in Diabetic Nephropathy [Phase 2, Phase 3]

See pricing